NEW YORK (GenomeWeb News) – Precision for Medicine, a Chevy Chase, Md.-based startup offering a variety of services for life science companies, has brought in $150 million in private funding, the firm said this week.

The company is focused on providing bioservices, such as biobanking, biospecimen management, and biomarker identification and validation, as well as consulting and advisory services for firms developing or offering products for "patient-centered, precision medicine."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.